CA1215976A - Nouvelle methode pour la synthese d'imidazorifamycines - Google Patents

Nouvelle methode pour la synthese d'imidazorifamycines

Info

Publication number
CA1215976A
CA1215976A CA000480320A CA480320A CA1215976A CA 1215976 A CA1215976 A CA 1215976A CA 000480320 A CA000480320 A CA 000480320A CA 480320 A CA480320 A CA 480320A CA 1215976 A CA1215976 A CA 1215976A
Authority
CA
Canada
Prior art keywords
alkyl
pyridine
amino
rifamycin
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000480320A
Other languages
English (en)
Inventor
Vincenzo Cannata
Gain F. Tamagnone
Manuela Campana
Silvano Piani
Giovanni Da Roit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Farmaceutici SpA
Original Assignee
Alfa Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT03464/84A external-priority patent/IT1199375B/it
Priority claimed from IT03465/84A external-priority patent/IT1199376B/it
Application filed by Alfa Farmaceutici SpA filed Critical Alfa Farmaceutici SpA
Application granted granted Critical
Publication of CA1215976A publication Critical patent/CA1215976A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000480320A 1984-05-15 1985-04-29 Nouvelle methode pour la synthese d'imidazorifamycines Expired CA1215976A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT3464A/84 1984-05-15
IT3465A/84 1984-05-15
IT03464/84A IT1199375B (it) 1984-05-15 1984-05-15 Processo per la preparazione di imidazo rifamicine
IT03465/84A IT1199376B (it) 1984-05-15 1984-05-15 Processo per la preparazione di imidazo-rifamicine

Publications (1)

Publication Number Publication Date
CA1215976A true CA1215976A (fr) 1986-12-30

Family

ID=26325399

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000480320A Expired CA1215976A (fr) 1984-05-15 1985-04-29 Nouvelle methode pour la synthese d'imidazorifamycines

Country Status (9)

Country Link
AR (1) AR242795A1 (fr)
AT (1) AT386829B (fr)
CA (1) CA1215976A (fr)
DK (1) DK160829C (fr)
ES (1) ES543116A0 (fr)
FI (1) FI83874C (fr)
GR (1) GR851146B (fr)
NO (1) NO164030C (fr)
PT (1) PT80447B (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709634B2 (en) 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
WO2010067072A1 (fr) 2008-12-10 2010-06-17 Cipla Limited Complexes de rifaximine
US7902206B2 (en) 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US7906542B2 (en) 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US7915275B2 (en) 2003-11-07 2011-03-29 Alfa Wassermann, S.P.A. Use of polymorphic forms of rifaximin for medical preparations
US8193196B2 (en) 2005-03-03 2012-06-05 Alfa Wassermann, S.P.A. Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
US8633234B2 (en) 2006-09-22 2014-01-21 Cipla Limited Rifaximin
US9452157B2 (en) 2012-07-06 2016-09-27 Alfa Wassermann S.P.A Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereof
EP3134415A4 (fr) * 2014-04-19 2017-10-25 Granules India Limited Procédé amélioré pour la préparation de dérivés de la rifamycine
US10428086B2 (en) 2014-05-12 2019-10-01 Alfasigma S.P.A. Solvated crystal form of rifaximin, production, compositions and uses thereof
US10556915B2 (en) 2014-03-31 2020-02-11 Euticals Spa Polymorphic mixture of Rifaximin and its use for the preparation of solid formulations

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173801B2 (en) 2003-11-07 2012-05-08 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US8404704B2 (en) 2003-11-07 2013-03-26 Alfa Wassermann S.P.A. Use of polymorphic forms of rifaximin for medical preparations
US7902206B2 (en) 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US7915275B2 (en) 2003-11-07 2011-03-29 Alfa Wassermann, S.P.A. Use of polymorphic forms of rifaximin for medical preparations
US8158644B2 (en) 2003-11-07 2012-04-17 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US8158781B2 (en) 2003-11-07 2012-04-17 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US7906542B2 (en) 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US8518949B2 (en) 2005-03-03 2013-08-27 Alfa Wassermann S.P.A. Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
US8193196B2 (en) 2005-03-03 2012-06-05 Alfa Wassermann, S.P.A. Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
US10703763B2 (en) 2005-03-03 2020-07-07 Alfasigma S.P.A. Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
US8633234B2 (en) 2006-09-22 2014-01-21 Cipla Limited Rifaximin
US7709634B2 (en) 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
US8916193B2 (en) 2008-12-10 2014-12-23 Cipla Limited Rifaximin complexes
WO2010067072A1 (fr) 2008-12-10 2010-06-17 Cipla Limited Complexes de rifaximine
US9452157B2 (en) 2012-07-06 2016-09-27 Alfa Wassermann S.P.A Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereof
US10556915B2 (en) 2014-03-31 2020-02-11 Euticals Spa Polymorphic mixture of Rifaximin and its use for the preparation of solid formulations
US10745415B2 (en) 2014-03-31 2020-08-18 Amri Italy S.R.L. Polymorphic mixture of Rifaximin and its use for the preparation of solid formulations
US10961257B2 (en) 2014-03-31 2021-03-30 Amri Italy S.R.L. Polymorphic mixture of rifaximin and its use for the preparation of solid formulations
US11739099B2 (en) 2014-03-31 2023-08-29 Curia Ip Holdings, Llc Polymorphic mixture of Rifaximin and its use for the preparation of solid formulations
EP3134415A4 (fr) * 2014-04-19 2017-10-25 Granules India Limited Procédé amélioré pour la préparation de dérivés de la rifamycine
US10428086B2 (en) 2014-05-12 2019-10-01 Alfasigma S.P.A. Solvated crystal form of rifaximin, production, compositions and uses thereof

Also Published As

Publication number Publication date
AT386829B (de) 1988-10-25
ES8603490A1 (es) 1986-01-01
DK160829B (da) 1991-04-22
ATA145085A (de) 1988-03-15
NO164030C (no) 1990-08-22
DK214585D0 (da) 1985-05-14
NO164030B (no) 1990-05-14
ES543116A0 (es) 1986-01-01
AR242795A1 (es) 1993-05-31
PT80447A (en) 1985-06-01
PT80447B (pt) 1987-11-11
FI83874C (fi) 1991-09-10
FI83874B (fi) 1991-05-31
FI851908L (fi) 1985-11-16
NO851920L (no) 1985-11-18
FI851908A0 (fi) 1985-05-14
DK160829C (da) 1991-10-07
DK214585A (da) 1985-11-16
GR851146B (fr) 1985-11-25

Similar Documents

Publication Publication Date Title
US4557866A (en) Process for the synthesis of pyrido-imidazo rifamycins
CA1215976A (fr) Nouvelle methode pour la synthese d'imidazorifamycines
EP0744400A2 (fr) Procédé pour la préparation de l'acide 4-trifluorométhylnicotinique
US5026843A (en) Process for the preparation of ceftriaxone
JP3268530B2 (ja) 5―メチル―N―(アリール)―1,2,4―トリアゾロ〔1,5―a〕ピリミジン―2―スルホンアミドの水性製造方法
US3794642A (en) Oxidation of substituted methanes to the corresponding substituted methanols
CA1218650A (fr) Synthese des pyrido-imidazo-rifamycines
US4031108A (en) 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane
US4959495A (en) Process for the preparation of intermediates used to produce aminothiazoloximino cephalosporins
US4417047A (en) Novel tetrazole-5-thiol ester and process for preparing cefamandole using same
US4515958A (en) Process for preparing 1-alkyl-5-mercaptotetrazoles
US3364198A (en) Process for the production of n6-methyltubercidin and intermediate
US3585184A (en) 2-amino - 2 - deoxy-d-glucopyrano-d-glucopyranans having the alpha-d-glucose configuration,method,and use
EP0233607B1 (fr) [(2,2,2-Trichloroéthoxy)méthoxy]amine
CA1197504A (fr) Procede et intermediaires pour la preparation du 6'-amino penicillanoyloxymethyl penicillinate 1,1 dioxyde
KR950000470B1 (ko) β-치환된-N-카르보벤족시-L-아스파르테이트의 제조방법
HU198179B (en) Process for producing n-methyl-1-alkylthio-2-nitroethenamine derivatives
US6051695A (en) Process for preparing erythromycin derivative, such as roxithromycin, from the corresponding oxime
US3557134A (en) 5,6-dihydro-5,6-substituted-3h-imidazo-(2,1-c)-1,2,4-dithiazole-3-thiones
KR970004046B1 (ko) 세팔로스포린 유도체의 제조방법
HU197308B (en) Process for preparing 2,6-bis(hydroxy-methyl)-pyridine-2,6-bis(n-methyl-carbamate)
US5066799A (en) Intermediates for the preparation of aminothiazoloximino cephalosporins
KR870000723B1 (ko) 페니실린 유도체의 제조방법
KR810000454B1 (ko) 치환 안식향산아미드 유도체의 제조방법
GB2116554A (en) Pyrimidinedicarbamates

Legal Events

Date Code Title Description
MKEX Expiry